| FAQ/Help |
| Calendar |
| Search |
| Today's Posts |
10-23-2012, 08:47 AM
|
#1 | ||
|
|||
|
Magnate
|
|
||
|
 Reply With Quote
|
|
10-24-2012, 09:24 PM
|
#2 | |||
|
||||
|
Senior Member
|
That's what a pop-up says when you pay this website a visit. If you "No" you are not a healthcare professional, it wont let you access everything about ODM-101. This is a new levodopa product that after Phase ZII trials, has been shown to be more efficacious than Stalevo AND without thr dife effect of dyskinesia.
So this is one to keep an eye on, as it may make it thru Phase III . However, this is Orion, a Finnish company sponsor, so the wait for the US might be longer (sigh) Peg |
|||
|
|
Reply With Quote
|
| "Thanks for this!" says: | soccertese (10-25-2012) |
| Reply |
|
|
Similar Threads
|
||||
| Thread | Forum | |||
| Does levodopa accelerate the pathologic process in Parkinson disease brain | Parkinson's Disease | |||
| Positive Results With Extended-Release Carbidopa-Levodopa | Parkinson's Disease | |||
| A study of Parkinson's disease in Carbidopa And Levodopa: who, when, how? | Parkinson's Disease | |||
| WE MOVE News...Continuous Levodopa for the Treatment of Parkinson Disease | Parkinson's Disease | |||
| Rotigotine As Levodopa Adjunct Is Effective In Advanced Parkinson's Disease | Parkinson's Disease | |||
Positive results of new levodopa product for Parkinson's disease
Linear Mode
